论文部分内容阅读
John Ross:这一临床讨论会的主要目的,着重于阐述当前普遍承认的一种心脏病——肥厚性心肌病的诊断和治疗进展。认识本病大约只有15年。在这一期间,本病的命名以及病理生理学曾引起许多争论。尽管如此,关于肥厚性心肌病在心脏病范畴中的地位,目前相对地已很清楚。可以认为,它的地位相当于其他的一些心脏疾病,诸如冠心病、瓣膜病(二尖瓣狭窄、二尖瓣关闭不全、先天性和获得性主动脉瓣狭窄)、乳头肌功能不全、二尖瓣脱垂综合征、先天性心脏病以及其它原发性和继发性心肌病等。肥厚性心肌病
John Ross: The main purpose of this clinical session focuses on the diagnosis and treatment of hypertrophic cardiomyopathy, a commonly recognized heart disease. Know about the disease is only about 15 years. During this period, the naming of the disease and pathophysiology have aroused much debate. Despite this, the status of hypertrophic cardiomyopathy in the context of heart disease is relatively clear at this stage. It can be assumed that its position is equivalent to other heart diseases such as coronary heart disease, valvular disease (mitral stenosis, mitral regurgitation, congenital and acquired aortic stenosis), papillary muscle dysfunction, Valvular prolapse syndrome, congenital heart disease and other primary and secondary cardiomyopathy. Hypertrophic cardiomyopathy